Hundreds of Clinics May Be Guilty of False or Misleading Claims in Ketamine Advertising

Hundreds of clinics may be using false and misleading statements in online advertising campaigns by offering off-label and unapproved ketamine to treat a variety of mental health and pain conditions, according to researchers at the University of Colorado Anschutz Medical Campusand Johns Hopkins University.


Click here to view original post